Story Street Research

Merrimack Pharmaceuticals, Inc. is a biopharmaceutical company headquartered in Cambridge, Massachusetts. The company's primary focus is on receiving contingent milestone payments from the sale of ONIVYDE to Ipsen S.A. in April 2017. Operating without any ongoing research or development activities, Merrimack Pharmaceuticals utilizes external consultants for its operations and does not have any employees. The company's business model centers around its entitlement to milestone payments and strategic partnerships within the biopharmaceutical industry.Generated from the website

New Boston Fund is a real estate investment firm based in Boston, MA, specializing in various development projects across the United States. The company focuses on innovative strategies in real estate services, including pre-leased developments, residential projects, and value-add acquisitions. With a commitment to strategic partnerships and community involvement, New Boston Fund delivers opportunities across a diverse portfolio that includes properties in locations such as Doral, FL, and Charlotte, NC. Their approach encompasses both core plus and opportunistic investment strategies to maximize value in the real estate market. Generated from the website